Patent details

Basic Information

Publication number:

EP3192809

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171533805

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-BAFF-ANTI-IL-17 BISPECIFIC ANTIBODIES

French Title of Invention:

ANTICORPS BISPÉCIFIQUES ANTI-BAFF-ANTI-IL-17

German Title of Invention:

BISPEZIFISCHE ANTI-BAFF- UND ANTI-IL-17-ANTIKÖRPER

SPC Number:

Dates

Filing date:

16/04/2013

Grant date:

15/04/2020

EP Publication Date:

19/07/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/04/2020

EP B1 Publication Date:

15/04/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/04/2020

Expiration date:

16/04/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/04/2020

 

 

Name:

Eli Lilly and Company

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

1

Name:

Benschop, Robert Jan

Address:

United States (US)

2

Name:

Jirong, Lu

Address:

United States (US)

3

Name:

Barrett, Allan

Address:

United States (US)

Priority

1

Priority Number:

201261636302 P

Priority Date:

20/04/2012

Priority Country:

United States (US)

2

Priority Number:

201361768747 P

Priority Date:

25/02/2013

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/24; C07K 16/28; C07K 16/46;

Publication

European Patent Bulletin

Issue number:

202016

Publication date:

15/04/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages